Results 171 to 180 of about 5,125,322 (307)

Estrogen Receptors and Breast Cancer: A New Approach to the Cut-off Problem

open access: yesThe International Journal of Biological Markers, 1988
C. Bozzetti   +7 more
doaj   +1 more source

Integrated Cardio-oncology Service. [PDF]

open access: yesCard Fail Rev
Butel-Simoes LE   +8 more
europepmc   +1 more source

How to Build a Cardio-Oncology Service? [PDF]

open access: yesEuropean Journal of Heart Failure, 2018
Farmakis, D.   +2 more
openaire   +3 more sources

Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations on the Role of Multidisciplinary Care

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Asparaginase is a critical treatment component for patients with acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). However, the successful delivery of asparaginase‐based therapy remains challenging across care settings due to its complex administration, distinct toxicity profile, prolonged treatment duration, and the need for ...
Amir Ali   +8 more
wiley   +1 more source

Parent Experiences Accessing Inpatient Clinical Notes on a Pediatric Oncology Service. [PDF]

open access: yesHosp Pediatr
Kieren MQ   +8 more
europepmc   +1 more source

Gynecological Oncology Service in Krasnodar Region: History of its Formation, Current Status

open access: yes
The history of the creation and organization of oncology services in Kuban, and particularly gynecologic oncology, are crucial for shaping the correct professional direction for future generations of oncologists.
Oncology Dispensary No. 3, Novorossiysk   +4 more
core   +1 more source

Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative strategy for acute myeloid leukemia (AML), but the impact of HLA disparity in the era of posttransplant cyclophosphamide (PTCy) and reduced‐toxicity conditioning remains unclear. We performed an EBMT registry study including 275 adult AML patients in first
Daniele Avenoso   +21 more
wiley   +1 more source

Phase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer   +38 more
wiley   +1 more source

Important learning points for setting up a dental-oncology service in Ireland. [PDF]

open access: yesIr J Med Sci
Byrne H   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy